ketanserin has been researched along with Shock in 3 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Shock: A pathological condition manifested by failure to perfuse or oxygenate vital organs.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We assess the effects of ipsapirone (a 5-HT1A receptor agonist), ketanserin (a 5-HT2A receptor antagonist), (-)-pindolol (a 5-HT1A receptor antagonist), and DOI (a 5-HT2A receptor agonist) on heatstroke in a rat model." | 7.73 | Ipsapirone and ketanserin protects against circulatory shock, intracranial hypertension, and cerebral ischemia during heatstroke. ( Chang, CP; Chen, SH; Lin, MT, 2005) |
| "Metabolites of arachidonic acid are possible mediators of local renal vasoconstriction in burn shock." | 7.68 | Renal vasoconstriction induced by arachidonic acid during burn shock in rats. ( Haugan, A; Kirkebø, A, 1990) |
| "We assess the effects of ipsapirone (a 5-HT1A receptor agonist), ketanserin (a 5-HT2A receptor antagonist), (-)-pindolol (a 5-HT1A receptor antagonist), and DOI (a 5-HT2A receptor agonist) on heatstroke in a rat model." | 3.73 | Ipsapirone and ketanserin protects against circulatory shock, intracranial hypertension, and cerebral ischemia during heatstroke. ( Chang, CP; Chen, SH; Lin, MT, 2005) |
| "Metabolites of arachidonic acid are possible mediators of local renal vasoconstriction in burn shock." | 3.68 | Renal vasoconstriction induced by arachidonic acid during burn shock in rats. ( Haugan, A; Kirkebø, A, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CP | 1 |
| Chen, SH | 1 |
| Lin, MT | 1 |
| Vincent, JL | 1 |
| Haugan, A | 1 |
| Kirkebø, A | 1 |
1 review available for ketanserin and Shock
| Article | Year |
|---|---|
Place of vasoactive agents in the treatment of acute circulatory failure.
Topics: Cardiac Output; Depression, Chemical; Dobutamine; Dopamine; Fluid Therapy; Humans; Ketanserin; Nitro | 1984 |
2 other studies available for ketanserin and Shock
| Article | Year |
|---|---|
Ipsapirone and ketanserin protects against circulatory shock, intracranial hypertension, and cerebral ischemia during heatstroke.
Topics: Anesthesia; Animals; Brain; Brain Ischemia; Corpus Striatum; Disease Models, Animal; Glutamic Acid; | 2005 |
Renal vasoconstriction induced by arachidonic acid during burn shock in rats.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Biphenyl Compounds; Burns; Epoprostenol; Ketanserin; M | 1990 |